000 01231 a2200337 4500
005 20250517164515.0
264 0 _c20180124
008 201801s 0 0 eng d
022 _a2405-8025
024 7 _a10.1016/j.trecan.2016.07.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCory, Suzanne
245 0 0 _aTargeting BCL-2-like Proteins to Kill Cancer Cells.
_h[electronic resource]
260 _bTrends in cancer
_c08 2016
300 _a443-460 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
650 0 4 _aAniline Compounds
_xtherapeutic use
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aApoptosis
650 0 4 _aBridged Bicyclo Compounds, Heterocyclic
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xantagonists & inhibitors
650 0 4 _aSulfonamides
_xtherapeutic use
700 1 _aRoberts, Andrew W
700 1 _aColman, Peter M
700 1 _aAdams, Jerry M
773 0 _tTrends in cancer
_gvol. 2
_gno. 8
_gp. 443-460
856 4 0 _uhttps://doi.org/10.1016/j.trecan.2016.07.001
_zAvailable from publisher's website
999 _c27400409
_d27400409